NewAmsterdam Pharma Company N.V.
NAMS · Healthcare · $2.8B
Pre-market $24.89+2.34%
Price
$34.83
$23.81
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue$4M+21.7%
Operating Income-$65M-11.0%
Net Income-$64M-32.4%
3/'26 vs prev quarter
Company Health
Market Cap$2.8B
Operating Margin-3432.2%
Cash on Hand$634M22.3% of market cap
Free Cash Flow$-144M-5.1% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR399.3xmedian 11.4xPBR4.5xmedian 2.0xROE-41.1%median -54.5%
